Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Centogene N.V.

Centogene N.V. (CNTG) Stock Overview

Explore Centogene N.V.’s financial performance, market position, analyst ratings, and future outlook.

CNTG●NASDAQ
HealthcareMedical - Diagnostics & Research
$0.33
$0.00(0.00%)
U.S. Market opens in 13h 59m

Centogene N.V. (CNTG)

Meyka AI Score

Z

Key Financials

Market Cap9.4M
P/E Ratio-0.22
EPS (TTM)$-1.39
ROE3.98%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

CNTG Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Centogene N.V. (NASDAQ: CNTG) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Centogene N.V.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of CNTG on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.

Key metrics behind Centogene N.V.'s NASDAQ-traded stock include a P/E ratio of -0.22 and a market capitalization of 9.4M. Combined with our AI analysis, these give both institutional and retail investors a clear view of CNTG on the NASDAQ.

Price Performance (NASDAQ: CNTG)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
91.29%
Year-to-Date (YTD) Change
150.00%
1-Year Change
150.00%
3-Year Change
-65.05%
5-Year Change
-97.24%
All-Time (Max) Change
-97.40%

Contact Information

https://www.centogene.com
49 381 80113 500
Am Strande 7, Rostock, NaN, 18055

Company Facts

3,840 Employees
IPO DateNov 7, 2019
CountryDE

Frequently Asked Questions